Should I Buy ANGI? ANGI 2026 Analysis

Should You Buy Angi Inc (ANGI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

13.470

1 Day change

0.82%

52 Week Range

20.700

Analysis Updated At

2026/01/28

Not a good buy right now for a beginner long-term investor who is impatient. ANGI’s fundamentals are still deteriorating (Q3 2025 revenue, earnings, and net income all down sharply YoY), analyst price targets were recently cut (both firms stay Neutral), and there are no fresh news catalysts to justify buying immediately. While technicals show a mild upswing, the stock is trading into nearby resistance around 13.35–13.66, making the risk/reward unattractive for an immediate entry.

Technical Analysis

Pre-market around 13.4 (+0.30%), ANGI is slightly above R1 (13.345) and below R2 (13.664), meaning it’s pushing into resistance rather than rebounding from support. Momentum is improving: MACD histogram is positive (0.0251) and expanding, which supports a short-term upward bias. RSI(6) at ~62.7 is neutral-to-slightly-bullish (not overbought), and moving averages are converging (often a transition phase rather than a strong established trend). Key levels: Pivot 12.83 is the main nearby “line in the sand”; below that, downside opens toward ~12.31 (S1). Given price is already at/above the first resistance zone, it’s not an attractive ‘buy-now’ long-term entry for an impatient investor.

Options Data

Bearish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Options positioning is mixed. Open interest put/call at 1.25 suggests heavier put positioning (more hedging or cautious sentiment). However, the volume put/call at 0.58 indicates today’s flow is more call-leaning (more near-term bullish trading). Implied volatility is very elevated (30D IV ~72.7% vs historical vol ~39.9%), implying the market is pricing larger moves than usual. Today’s option activity is unusual versus recent averages (volume ~18x the 30-day average and open interest ~93x average), but total contract counts are still relatively small—so sentiment signals can be noisy. Net: sentiment is not cleanly bullish enough to justify an immediate long-term buy.

Technical Summary

Sell

Buy

Positive Catalysts

1) Technical momentum is improving (positive and expanding MACD) and RSI is not overbought.
2) Gross margin improved YoY (Q3 2025 gross margin ~90.82%, +1.92% YoY), suggesting strong unit economics despite revenue pressure.
3) Next potential catalyst is earnings: QDEC 2025 earnings on 2026-02-10 (after hours). A return to positive revenue growth expectations could re-rate the stock, but that is not currently evidenced in the provided data.

Neutral/Negative Catalysts

1) Fundamentals are weak: Q3 2025 revenue down -10.48% YoY; net income down -69.84% YoY; EPS down -67.14% YoY.
2) Analyst tone is cautious with recent price target cuts (both remain Neutral), signaling limited conviction on near-term upside.
3) No supportive news flow in the last week; no clear event-driven catalyst pushing demand today.
4) Price is pressing into resistance (13.35–13.66 area), increasing the odds of a stall/pullback rather than a clean breakout.

Financial Performance

Latest quarter: 2025/Q3. Growth trends are negative: Revenue fell to $265.633M (-10.48% YoY). Profitability also weakened significantly: Net income $10.605M (-69.84% YoY) and EPS $0.23 (-67.14% YoY). The bright spot is margin: gross margin rose to 90.82% (+1.92% YoY). Overall, the business is showing declining top-line and earnings power despite strong margins—this is not the profile of a clear long-term ‘buy now’ for a beginner without a strong catalyst.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: Analysts have been cutting price targets while keeping Neutral ratings. UBS (2025-11-10) cut PT to $15 from $22 (Neutral), citing topline weakness from softer network/unbranded SEO channels but expecting easing into 2026 as traffic mix improves; UBS also notes valuation/free cash flow yield may limit downside, with interest returning when revenue growth turns positive in 2026. Goldman Sachs (2025-11-06) cut PT to $27 from $32 (Neutral). Wall Street pros: potential limited downside if free cash flow yield is strong and if revenue growth re-accelerates in 2026. Wall Street cons: current topline weakness and reduced forward EBITDA expectations; near-term growth visibility is not strong. Influential/insider/political flow: Hedge funds neutral and insiders neutral; no recent Congress trading data available.

7 Analyst Rating

Wall Street analysts forecast ANGI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ANGI is 20.17 USD with a low forecast of 14 USD and a high forecast of 27 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

4 Hold

0 Sell

Moderate Buy

Current: 13.360

Low

Averages

20.17

High

Current: 13.360

Low

Averages

20.17

High

UBS

Neutral

downgrade

$22 -> $15

AI Analysis

2025-11-10

Reason

UBS

Price Target

$22 -> $15

AI Analysis

2025-11-10

downgrade

Neutral

Reason

UBS lowered the firm's price target on Angi Inc. to $15 from $22 and keeps a Neutral rating on the shares. Topline weakness stemmed from softer network and unbranded SEO channels, though these pressures should ease into 2026 as traffic mix improves, the analyst tells investors in a research note. Despite reduced EBITDA estimates for 2026-2027, Angi's valuation and strong free cash flow yield suggest limited downside, with investor interest likely to return once revenue growth turns positive in 2026, UBS says.

Goldman Sachs

Neutral

downgrade

$32 -> $27

2025-11-06

Reason

Goldman Sachs

Price Target

$32 -> $27

2025-11-06

downgrade

Neutral

Reason

Goldman Sachs lowered the firm's price target on Angi Inc. to $27 from $32 and keeps a Neutral rating on the shares.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ANGI

Unlock Now

ANGI Should I Buy

ANGI Should I Buy

Should You Buy Angi Inc (ANGI) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch